Unicycive Therapeutics
UNCY
UNCY
20 hedge funds and large institutions have $24.6M invested in Unicycive Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3M | |
| 2 | +$134K | |
| 3 | +$72.9K | |
| 4 |
Lazard Asset Management
New York
|
+$71.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.36K |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$1.86M | |
| 3 | -$1.39M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.07M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.01M |